Aptevo Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -222.3% | -163.0% | -122.4% |
| FY2017 | 8.5% | 7.1% | 6.0% |
| FY2018 | -176.6% | -108.1% | -79.5% |
| FY2019 | -341.6% | -341.6% | -75.7% |
| FY2020 | -107.0% | -39.6% | -33.1% |
| FY2021 | -2,340.2% | -578.0% | -50.3% |
| FY2022 | 44.7% | 41.3% | 23.5% |
| FY2023 | -142.5% | -142.5% | -70.1% |
| FY2024 | -507.5% | -507.5% | -154.8% |
| FY2025 | -149.4% | -149.4% | -95.5% |